A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Cas9, scientists reconstitute live African swine fever virus from synthetic genomes, accelerating vaccine development for ...

This self-helper virus is an inhibited version of ASFV which has been modified using CRISPR/Cas9 technology, a powerful gene-editing tool that can precisely cut DNA at specific locations.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

In a new experimental study, scientists from Juntendo University in collaboration with researchers from the University of Tokyo have developed an adeno-associated virus (AAV) vector-mediated ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock Research Institute (ILRI) ...

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that ...

"This is conceptually similar to a vaccine with an attenuated virus," says Nicholas Keith, a graduate student and first author of the paper. "We believe this is the reason why the CRISPR Cas9 ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas ... Here, authors introduce the CRISPR-VIM, using virus-like particles to efficiently deliver CRISPR tools into zygotes without physical damage ...

This self-helper virus is an inhibited version of ASFV which has been modified using CRISPR/Cas9 technology, a powerful gene-editing tool that can precisely cut DNA at specific locations.

GeneVentiv Therapeutics, a gene therapy company, today announced it has signed a global licensing agreement with Duke ...